{
    "2020-09-01": [
        [
            {
                "time": "",
                "original_text": "贝达药业（300558.SZ）：股东济和创投解除质押190万股",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "股东",
                        "济和创投",
                        "解除质押",
                        "190万股"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "贝达药业今日大宗交易成交10万股，成交价129.0元折价0.39%",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "大宗交易",
                        "10万股",
                        "129.0元",
                        "折价0.39%"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "绩优基金何以表现亮眼，聪明钱与好公司互相成就",
                "features": {
                    "keywords": [
                        "绩优基金",
                        "表现亮眼",
                        "聪明钱",
                        "好公司"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "上市公司创新药8月报告：第一梯队在研品种近百个，抗肿瘤药占半壁江山",
                "features": {
                    "keywords": [
                        "上市公司",
                        "创新药",
                        "8月报告",
                        "第一梯队",
                        "在研品种",
                        "抗肿瘤药"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}